Metraipolis › archive › dc_458c607af346

Triplet RNA Lipid Nanoparticles for Locoregional Cancer Immunotherapy — Europe PMC PMID:41532074

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41532074
DOI
10.1002/smsc.202500506
License (as archived)
solo-consultazione
Archived
2026-11-07T17:04:51.309Z
SHA-256 of the archived text
be5368de65f8d18352c796d8c96ff01f4eeab4dfad9bbc56c1fc416801c52fc4
Stable URL of this page
https://metraipolis.com/documento/dc_458c607af346

How to cite

Triplet RNA Lipid Nanoparticles for Locoregional Cancer Immunotherapy — Europe PMC PMID:41532074 — Europe PMC (en), https://europepmc.org/article/MED/41532074 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_458c607af346 (Metraipolis archive dc_458c607af346, sha256 be5368de65f8d18352c796d8c96ff01f4eeab4dfad9bbc56c1fc416801c52fc4)
BibTeX
@misc{dc458c607af346,
  title = {Triplet RNA Lipid Nanoparticles for Locoregional Cancer Immunotherapy — Europe PMC PMID:41532074},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41532074},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_458c607af346; sha256 be5368de65f8d18352c796d8c96ff01f4eeab4dfad9bbc56c1fc416801c52fc4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41532074. Agents can read the archived copy with the MCP tool read_document.